Sync Biosystems

Sync Biosystems has been founded in 2022 with the aim to bring Organs-on-Chips and Microphysiological Systems to real-world applications. Being part of the Demcon group, the company has access to an extensive source of engineering and data analytics knowledge. We strongly believe that with high tech engineering we can improve current biological assays by introducing precise control,(pharma)kinetics and continuous readout of biological in vitro model systems. Drug testing and disease modelling can become easier and more reliable with the right technological tools. We create a bridge between in vitro biology, microfluidics and mechatronics to add possibilities to existing assays without increasing the complexity of protocols.